Next Article in Journal
Reclassification of TCGA Diffuse Glioma Profiles Linked to Transcriptomic, Epigenetic, Genomic and Clinical Data, According to the 2021 WHO CNS Tumor Classification
Next Article in Special Issue
Spotlight on CYP4B1
Previous Article in Journal
A Novel Molecular Signature of Cancer-Associated Fibroblasts Predicts Prognosis and Immunotherapy Response in Pancreatic Cancer
Previous Article in Special Issue
Human Orphan Cytochrome P450 2U1 Catalyzes the ω-Hydroxylation of Leukotriene B4
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 24
Issue 1
10.3390/ijms24010149
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Saprophytic to Pathogenic Mycobacteria: Loss of Cytochrome P450s Vis a Vis Their Prominent Involvement in Natural Metabolite Biosynthesis

by
Ntokozo Minenhle Zondo
1,†,
Tiara Padayachee
1,†,
David R. Nelson
2,* and
Khajamohiddin Syed
1,*
1
Department of Biochemistry and Microbiology, Faculty of Science and Agriculture, University of Zululand, KwaDlangezwa 3886, South Africa
2
Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, TN 38163, USA
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Int. J. Mol. Sci. 2023, 24(1), 149; https://doi.org/10.3390/ijms24010149
Submission received: 8 September 2022 / Revised: 12 December 2022 / Accepted: 16 December 2022 / Published: 21 December 2022
(This article belongs to the Special Issue Cytochromes P450: Drug Metabolism, Bioactivation and Biodiversity 4.0)
Browse Figures
Versions Notes

Abstract

:
Cytochrome P450 monooxygenases (P450s/CYPs) are ubiquitous enzymes with unique regio- and stereo-selective oxidation activities. Due to these properties, P450s play a key role in the biosynthesis of natural metabolites. Mycobacterial species are well-known producers of complex metabolites that help them survive in diverse ecological niches, including in the host. In this study, a comprehensive analysis of P450s and their role in natural metabolite synthesis in 2666 mycobacterial species was carried out. The study revealed the presence of 62,815 P450s that can be grouped into 182 P450 families and 345 subfamilies. Blooming (the presence of more than one copy of the same gene) and expansion (presence of the same gene in many species) were observed at the family and subfamily levels. CYP135 was the dominant family in mycobacterial species. The mycobacterial species have distinct P450 profiles, indicating that lifestyle impacts P450 content in their genome vis a vis P450s, playing a key role in organisms’ adaptation. Analysis of the P450 profile revealed a gradual loss of P450s from non-pathogenic to pathogenic mycobacteria. Pathogenic mycobacteria have more P450s in biosynthetic gene clusters that produce natural metabolites. This indicates that P450s are recruited for the biosynthesis of unique metabolites, thus helping these pathogens survive in their niches. This study is the first to analyze P450s and their role in natural metabolite synthesis in many mycobacterial species.

1. Introduction

Cytochrome P450 monooxygenases (CYPs/P450s) are undoubtedly one of the most extensively studied enzymes due to their role in organisms’ primary and secondary metabolism [1,2,3]. The word “cytochrome” indicates the presence of a chromophore such as heme as a prosthetic group, and “P450” denotes their characteristic absorbance spectrum of 450 nm wavelength when they are reduced and complexed with carbon monoxide [4,5,6,7]. The word “monooxygenase” indicates the incorporation of one oxygen into substrates by these enzymes [4,5,6,7,8]. However, since their discovery, it has been observed that P450s catalyze diverse enzymatic reactions with regio- and stereo-selectivity [9,10,11]. Due to their unique enzymatic properties, P450s were exploited for their biomedical and biotechnological applications [12,13,14,15,16,17].
P450s are ubiquitous, as they have been found in living and non-living entities such as viruses [3,18]. The International P450 Nomenclature Committee developed a nomenclature and annotation method for correctly identifying P450s in species across all the biological kingdoms [19,20,21]. The nomenclature system begins with the prefix “CYP” for cytochrome P450 monooxygenase, followed by an Arabic numeral designating the family, a capital letter representing the subfamily, and an Arabic digit specifying the individual P450 in a family. The annotation criteria include assigning family and subfamily with >40% identity belonging to the same family and all P450s with >55% identity belonging to the same subfamily [19,20,21,22]. All researchers have universally accepted this nomenclature and annotation method; thus, any P450 identified should be subjected to this criterion for its proper identification.
The application of P450 in synthesizing natural metabolites has gained momentum [23,24,25]. Natural products are metabolites, either primary or secondary, produced by organisms. Primary metabolites are involved in organisms’ physiology. In contrast, secondary metabolites, although they have no direct role in organisms’ physiology, tend to play a role indirectly in helping organisms survive. The ongoing genome sequencing rush revealed many P450s from the species across the biological kingdom [3]. It is impossible to clone, express, and characterize many P450s. Due to this hurdle, an in silico analysis of P450s will help understand their role in different biological processes including in the biosynthesis of natural products.
In silico studies based on the genome-wide analysis of P450s and their role in the biosynthesis of natural products revealed the presence of many P450s in biosynthetic gene clusters (BGCs) in bacterial species. BGCs are physical groupings of two or more genes in a genome that is responsible for the biosynthesis of a metabolite [26]. An analysis of BGCs across different bacterial species revealed that Salinispora species have the highest percentage of P450s, and Bacteroidetes species and cyanobacterial species have the lowest percentage of P450s as part of BGCs [27,28,29,30,31,32,33,34,35,36,37]. The percentage of P450s as part of BGCs from highest to lowest is as follows: Salinispora species (47%) > Streptomyces species (23% > Firmicutes species (18%) > mycobacterial species (15%) > proteobacterial species (12%) > Bacteroidetes species = cyanobacterial species (8%).
Mycobacterial P450s gained attention due to their potential as drug targets [38] and for the production of valuable human metabolites [39]. CYP121A1 and CYP128A1 from Mycobacterium tuberculosis H37Rv are involved in the biosynthesis of natural metabolites mycocyclosin [37,39,40,41] and sulfomenaquinone [40]. A point to be noted is that CYP121A1 is essential for the survival of M. tuberculosis, indicating that the metabolite it synthesizes is a vital primary metabolite [37,39,40,41]. Menaquinone is a primary metabolite involved in the electron transport in M. tuberculosis [40]. CYP139 family members were found to be part of different BGC types, indicating their involvement in the biosynthesis of diverse natural compounds [41]. Based on the results, the authors proposed that these metabolites might provide mycobacterial species with advantageous traits in diverse niches competing with other microbial or viral agents and helping these microbes infect hosts by interfering with the host’s metabolism and immune system [41]. A genome-wide analysis of P450s in 60 mycobacterial species revealed that 15% of P450s belonging to 31 different families are part of BGCs [35]. It is well-known that mycobacterial species have complex metabolites as part of their cellular structure, and some of these metabolites are well-known for their virulence [42,43,44]. Based on P450s and their BGCs, the authors concluded that these P450s of BGCs possibly play a role in the synthesis of complex metabolites [36].
Previously mentioned studies are limited to a single family (CYP121, CYP128, and CYP139) and a few species (60 species). To date, a comprehensive analysis of P450s and their role in natural metabolites biosynthesis in a large number of mycobacterial species has not been carried out. This study aims to address this research gap to understand the role of P450s in natural product biosynthesis concerning different mycobacterial categories.

2. Results and Discussion

2.1. Saprophytic to Pathogen Life Style Led to the Loss of P450s in Mycobacterial Species

Genome-wide data mining and annotation for P450s in 2666 mycobacterial species revealed the presence of 62,815 P450s and 90 P450 fragments/pseudo genes in their genomes (Table 1 and Table S1). The 2666 mycobacterial species include Mycobacterium tuberculosis complex (MTBC) (2128 species), M. chelonae-abscessus complex (MCAC) (255 species), M. avium complex (MAC) (106 species), Mycobacteria causing leprosy (MCL) (four species), Nontuberculous mycobacteria (NTM) (163 species) and Saprophytes (SAP) (10 species). A comparative analysis with other bacterial species revealed that mycobacterial species have a high average number of P450s (24 P450s) compared to other bacterial species, only exceeded by Streptomyces species (27 P450s) (Table 1), which is in agreement with the previously mentioned studies. [36,37]. However, it is worthy of note that only 126 Streptomyces species data are available for comparison with 2666 mycobacterial species. Thus, analysis of more Streptomyces species probably bridges the gap and shows a similar trend to mycobacterial species. Nonetheless, it is clear that among the bacterial population, actinomycetes have the highest average number of P450s in their genomes (Table 1), indicating that P450s play a key role in their primary and secondary metabolism, including adaptation to diverse ecological niches as described elsewhere [35,36,37]. Among mycobacterial species, Mycolicibacterium rhodesiae JS60 has the highest (95 P450s), and Mycobacterium leprae Br492 has the lowest number of P450s (3 P450s) in their genomes (Table S1).
An analysis of the P450 profile of six mycobacterial categories revealed a gradual loss of P450s from SAP to MTBC (Table 2 and Table S1). The order is as follows: SAP (35–95:51) > MAC (28–69:48)  = NTM (9–89:48) > MCAC (22–52:26) > MTBC (5–74:20) > MCL (3–7:5), where the minimum and maximum number of P450s are shown, and after the semicolon, the average number of P450s, are shown in parentheses. This suggests that during the progression from a saprophytic to a pathogenic lifestyle, mycobacterial species lost P450s (Table 2 and Table S1). The P450 count differences observed among different mycobacterial groups were found to be statistically significant (Table S2). This phenomenon of the gradual loss of P450s in mycobacterial species from SAP to MTBC/MCL was previously reported [35]. However, in the previous study, only 60 mycobacterial species were analyzed [35]. The observation of the same phenomenon in this study, where many species (2666 species) were examined, strongly supports the hypothesis that mycobacterial species lost P450s in their genomes to adapt to diverse ecological niches. As described elsewhere [35,36,37,41,45], the P450s retained in these species played a crucial role in their adaptation to diverse ecological niches. A detailed analysis of P450 key features in six mycobacterial categories is presented in Table 2.

2.2. P450 Family and Subfamily Blooming/Expansion in Mycobacterial Species

Based on the International P450 Nomenclature Committee rules [19,20,22], the percentage identity of >40% for a family and >55% for a subfamily, the 62,815 P450s from 2666 mycobacterial species can be grouped into 182 P450 families and 345 P450 subfamilies (Figure 1 and Table S3). Among mycobacterial species, M. rhodesiae JS60 had the highest number of P450s and also had the highest number of P450 families (53) and subfamilies (75) (Table S1). No P450 family was conserved in the mycobacterial species (Table S1). Among 182 P450 families, 21 P450 families contributed 85% of the total P450s in the mycobacterial species (Figure 1 and Table S3), indicating their important role in these species. Among the P450 families, CYP135 is dominant with 4702 members, followed by CYP125 with 4085 members, CYP123 with 3019 members, and CYP136 with 3017 members (Figure 1 and Table S3). It is safe to say that these P450 families bloomed (present more than a member in a species) in mycobacterial species, considering the number of species analyzed in this study. The P450 families CYP138, CYP140, CYP144, CYP51, CYP130, CYP142, CYP124, CYP143, CYP126, CYP139, CYP128, CYP137, CYP132, CYP141, and CYP121 have members between 2000–3000, indicating their expansion in mycobacterial species (Figure 1 and Table S3). Contrary to the P450 families that bloomed/expanded, 43 P450 families had a single member, and 25 P450 families had only two members (Table S3).
Among P450 families, CYP107 had the highest number of subfamilies (15), followed by CYP125 (13 subfamilies) and CYP105 (11 subfamilies) (Table S3). The Blooming/expansion phenomenon is also observed at a P450 subfamily level (Table 3 and Table S3). A P450 subfamily analysis revealed that specific subfamilies were bloomed or expanded in mycobacterial species, indicating a selective preference for distinct subfamilies by the species (Table 3 and Table S3).
A comparative analysis with other bacterial species revealed that mycobacterial species have the highest number of P450 families and subfamilies, but only next to the Streptomyces species (Table 1). This suggests that the Streptomyces species has the highest P450 family and subfamily diversity compared to mycobacterial species (Table 1).

2.3. Different Mycobacterial Categories Have Distinct P450 Profiles

P450s play a key role in organisms’ adaptation vis a vis lifestyle impacts of P450 content in their genome [30,32,34,35,36,37]. This phenomenon is evident in mycobacterial species, as mycobacterial categories have distinct P450 profiles (Figure 2 and Table 2 and Table S4). Among mycobacterial categories, NTM had the highest number of P450 families and subfamilies (145 and 261), followed by SAP (66 and 101), MTBC (66 and 95), MAC (59 and 88), MCAC (37 and 48), and MCL (nine families and subfamilies) (Table 2 and Table S4). A point worthy of note is that despite the lower number of species analyzed for NTM (163 species) compared to MTBC (2128 species) and MCAC (255 species), NTM has the highest number of P450 families (145) and subfamilies (261) (Table 2 and Table S4). The same can be seen when comparing them to SAP and MTBC, where only ten species of SAP and 2128 species of MTBC had the same number of P450 families (Table 2 and Table S4). This indicates that NTM had a high P450 family and subfamily diversity among mycobacterial categories, indicative of diverse P450s in the species.
A P450 family conservation analysis revealed different P450 families conserved in different mycobacterial categories. CYP135 is conserved in MTBC, CYP125 is conserved in MCAC, CYP105 and CYP150 are conserved in MAC, CYP189 is conserved in SAP, and CYP164 is conserved in MCL (Tables S1 and S5). No P450 family was conserved in NTM, possibly due to the high P450 family diversity mentioned above. However, CYP125 was the dominant P450 family in NTM (Table 2). The analysis of unique and shared P450 families among mycobacterial categories revealed that NTM has the highest number of unique P450 families (71 families), followed by SAP (23 families), MAC (15 families), MTBC (11 families), and MCAC (six families) (Table 4 and Table S5). No P450 family was unique for MCL (Table 4 and Table S5). As indicated in Table 4, many P450 families are shared among mycobacterial groups. CYP105, CYP125, CYP150, and CYP189 families are dominantly shared across mycobacterial categories (Table 4 and Table S5). This indicates that these P450 families play an important role in mycobacterial species; thus, they are not only retained but also bloomed/expanded (Table 3). MCL shares the CYP136 and CYP164 families with other bacterial groups (Table 4).

2.4. CYP121, CYP124, and CYP128 P450s Are Part of the Same Biosynthetic Gene Cluster

An analysis of P450s involved in natural metabolite biosynthesis in the mycobacterial species revealed that a total of 9399 P450s out of 62,815 (15%) are part of BGCs (Table 1 and Table S6). Mycobacterial species have the highest percentage of P450s that are part of BGCs compared to cyanobacterial species, Bacteroidetes species, Firmicutes species, and proteobacterial species (Table 1). However, Streptomyces-, and Salinispora-species had the highest percentage of P450s part of BGCs compared to the mycobacterial species (Table 1). This indicates that actinomycetes have more P450s involved in natural metabolite biosynthesis among bacterial species and that particularly the Salinispora species have a larger percentage of P450s as a part of BGCs (Table 1). Among 182 P450 families identified in the mycobacterial species, only 68 P450 families (37%) are part of BGCs (Figure 3 and Table S6).
Among 68 P450 families that are part of BGCs, CYP139 was the most dominant with 2171 members, followed by CYP128 with 1960 members, CYP121 with 1953 members, and CYP124 with 1946 members (Figure 3 and Table S6). In total, these four P450 families contributed 85% of the P450s part of BGCs in mycobacterial species (Figure 3 and Table S6). A point to be noted is that these four P450 families possibly play a key role in natural metabolite biosynthesis, and thus are expanded in mycobacterial species (see Section 2.2). One example is CYP139 BGC clusters that are known to produce metabolites that provide mycobacterial species with advantageous traits in diverse niches competing with other microbial or viral agents, which might help these microbes infect hosts by interfering with the host’s metabolism and immune system [41]. CYP128 was found to play an essential role in producing a metabolite that acts as a negative regulator of virulence [40,46]. CYP121 is a crucial P450 and drug target against pathogenic mycobacterial species and is involved in synthesizing a metabolite named mycocyclosin [38,47,48,49]. CYP124 is a lipid hydroxylase and secondary drug target in pathogenic mycobacterial species [38,50,51]. A recent study reported that CYP128,CYP121, and CYP124 are part of the same BGC, indicating their collective role in synthesizing complex natural metabolites that play an important role in the mycobacterial species [46]. In this current study, we also observed that these three P450s are part of the same BGC (Table S6), further supporting the previous observation and conclusion on the collective role of these P450s in synthesizing natural metabolites in mycobacterial species [46].
Five P450 families: CYP144 with 216 members, CYP135 with 198 members, CYP1128 with 193 members, CYP150 with 132 members, and CYP187 with 130 members, contributed 9% of the P450s part of BGCs in mycobacterial species (Figure 3 and Table S7). The remaining 59 P450 families contributed only 6% of the P450s part of BGCs, indicating their minor role in natural metabolite biosynthesis in mycobacterial species (Figure 3 and Table S7). A point worthy of note is that with regard to CYP135, despite being the most dominant P450 family and CYP144 and CYP150 families being expanded in mycobacterial species (Figure 1), only a fraction of these family members are part of BGCs (Figure 3 and Table S7). Furthermore, the CYP125, CYP123, CYP136, CYP138, and CYP140 families, despite being bloomed/expanded (see Section 2.2), their role in natural metabolite biosynthesis is negligible as only a few members were found to be part of BGCs (Figure 3 and Table S6). This suggests that these P450s might be involved in key primary metabolism and thus are bloomed/expanded in these species. This also supports previous observations that the dominant P450 family may not necessarily play a role in natural metabolite biosynthesis [27,28,32,33,34,35,37]. Detailed information on the P450s part of BGCs, their species name, and BGC type and the similar known-gene cluster is presented in Table S6, and the data on the analysis of P450s that are part of BGCs is shown in Table S7.

2.5. More P450s Are Involved in Natural Metabolite Biosynthesis in Pathogenic Mycobacterial Species

The analysis of P450s involved in natural metabolite biosynthesis revealed that more P450s are part of BGCs in pathogenic mycobacteria compared to non-pathogenic bacteria (Figure 4 and Table 2 and Table S7). The number of P450s that are part of BGCs in MTBC was the highest (8153 P450s), followed by NTM (450 P450s), MCAC (438 P450s), MAC (328 P450s), and SAP (30 P450s) (Figure 4 and Table 2 and Table S7). As expected, due to reduced genome size and having few P450s in their genomes, MCL has no P450s as part of BGCs, and thus, we did not include MCL for comparative analysis, which is the same as followed elsewhere [35]. One can argue that the number of species analyzed for MTBC is the highest compared to other categories, and thus one can see the highest number of P450s as part of BGCs (Table 2). To clarify and nullify this argument, we have compared the percentage of P450s part of BGCs in different mycobacterial categories (Table 2). An analysis of the percentage of P450s part of BGCs revealed that, indeed, MTBC has the highest percentage of P450s (19%) part of BGCs, followed by MCAC (6.7%), MAC (6.4%), SAP (5.9%), and NTM (5.8%) (Table 2). This suggests that pathogenic mycobacterial species such as MTBC indeed have more P450s as part of BGCs and, thus, more P450s in these species involved in the biosynthesis of natural metabolites. The point to be noted is that MTBC has more P450 parts of BGCs (Table 2) despite having the lowest number of P450s in their genomes compared to MCAC, MAC, NTM, and SAP (Table 1). This indicates that P450s in MTBC may play a vital role in the biosynthesis of natural metabolites, thus helping these organisms survive in the host, as mentioned in Section 2.4.
Analysis of the P450 families part of BGCs revealed that NTM has the highest number of P450 families part of BGCs, followed by MTBC, SAP, MCAC, and MAC (Figure 4 and Table S7). The number of P450 families part of BGCs followed the same pattern as the number of P450 families in these categories, indicating that diverse P450s are indeed involved in natural metabolite biosynthesis in NTM (Figure 4 and Table 2). A clear picture emerged when we compared the percentage of P450 families as part of BGCs, where NTM still had the highest P450 families as part of the BGCs, followed by MCAC, MTBC, SAP, and MAC (Table 2). The lowest percentage of P450 families part of BGC indicates the blooming/expansion of a particular P450 family. This is true, as few P450 families are populated in BGCs in different mycobacterial categories (Figure 4 and Table S7). Four P450 families such as CYP139, CYP128, CYP121, and CYP124, have contributed 97% of P450 families as part of BGCs in MTBC; CYP150, CYP139, CYP187, and CYP105 families contributed 87% in MAC, and CYP1128 and CYP135 families contributed 83% in MCAC (Figure 4 and Table S7) indicating that these P450 families were preferred in these species possibly due to their importance in the natural product synthesis. Pathogenic mycobacterial species seem to have recruited more P450 families belonging to the same family for natural metabolite biosynthesis. In contrast, the non-pathogenic mycobacterial species have fewer and more diverse P450s for natural metabolite biosynthesis. This suggests that natural metabolites produced by MTBC play a role in their survival in the host (as mentioned in Section 2.4). Thus, P450s play a crucial role in synthesizing these metabolites.

3. Materials and Methods

3.1. Species and Their Genome Database Information

Mycobacterial species genomes (permanent and finished draft genomes) available for public use at the Joint Genome Institute Integrated Microbial Genomes and Microbiomes (JGI IMG/M) [52] were used in the study (last accessed on April 2022). Information on the species and their genome IDs used in the study is provided in Table S1.

3.2. Grouping of Mycobacterial Species

The mycobacterial species were grouped into six categories following the criteria described elsewhere [35]. The six categories include Mycobacterium tuberculosis complex (MTBC), M. chelonae-abscessus complex (MCAC), M. avium complex (MAC), Mycobacteria causing leprosy (MCL), nontuberculous mycobacteria (NTM), and Saprophytes (SAP). Briefly, mycobacterial species are grouped into six categories based on their characteristic features, including ecological niches and the nature and site of infection, as described elsewhere [53]. Also, a taxonomical grouping of mycobacterial species is considered as described elsewhere [54]. Mycobacterial species and their categories are presented in Table S1.

3.3. Genome Data Mining and Annotation of P450s

Genome data mining and the identification of P450s in mycobacterial species were carried out following the protocol described elsewhere [28,37,41]. Briefly, each mycobacterial species genome available at JGI IMG/M [52] was searched for P450s using the InterPro code “IPR001128”. The hit protein sequences were then searched for the presence of P450 characteristic motifs such as EXXR and CXG [55,56]. Proteins with one of these motifs or short amino acid length are considered as P450-fragments. P450 fragments were not considered for the final P450 family and subfamily count. Proteins having both motifs were selected for assigning the family and subfamilies. Following the International P450 Nomenclature Committee rule [19,20,22], proteins with >40% identity and >55% identity will be grouped under the same family and subfamily, respectively. P450s with less than 40% identity were assigned to a new P450 family. Mycobacterial species P450s identified in this study and their protein sequences, assigned names, and species are presented in Supplementary Dataset S1. Information on homolog P450s and percentage identity used to assign names for mycobacterial P450s is presented in Table S8.

3.4. Identification of P450s Part of BGCs

P450s that are part of BGCs were identified following the method described elsewhere [28,37,41]. Briefly, for each mycobacterial species genome available at JGI IMG/M [52], the BGCs were searched for the presence of P450s using the P450 gene ID. The cluster type is noted if a P450 is found as part of the cluster. The gene cluster sequence was downloaded and submitted to anti-SMASH (antibiotics and Secondary Metabolite Analysis Shell) [57] to find a similar known cluster. The results were recorded in Excel spreadsheets and represented species-wise smBGCs, smBGC type, percentage similarity to known gene clusters, and P450s part of specific BGCs.

3.5. P450 Key Features Analysis

All calculations were carried out following the procedure reported previously by our laboratory [29,30]. The average number of P450s was calculated using the formula: Average number of P450s = Number of P450s/Number of species. The percentage of P450s that formed part of BGCs was calculated using the formula: Percentage of P450s part of BGCs = 100 × Number of P450s part of BGCs/Total number of P450s present in species. The P450 family/subfamily is considered bloomed when a member count exceeds the number of species and expands when the member count exceeds >500. The statistical significance of the P450 count among different mycobacterial categories was calculated using Welch’s T-test calculator (https://www.statskingdom.com/150MeanT2uneq.html, accessed on 29 October 2022). The average number of P450s, standard deviation, and sample size were used as inputs. The results for the null hypothesis, p-value, T-value, and effect size (d) for different mycobacterial categories were presented in a tabular format (Table S2).

3.6. Comparative Analysis of P450s and BGCs Data

For comparative analysis of P450s and BGCs, information for bacterial species belonging to different groups such as phyla, Firmicutes [34], Bacteroidetes [32], Proteobacteria [30], and Cyanobacteria [27], and the genera Streptomyces [36,37], and Salinispora [28] was resourced from published articles.

4. Conclusions

Cytochrome P450 monooxygenases (CYPs/P450s) play a key role in synthesizing natural metabolites in organisms. They attribute diversity to the metabolites by performing unique regio- and stereo-selective oxidation reactions. Mycobacterial species have complex metabolites that help them survive in diverse ecological niches. Previous studies limited to a few P450 families or a few species indicated that P450s play a role in synthesizing natural metabolites in mycobacterial species. The availability of many mycobacterial genomes allowed us to look into the P450s role in the biosynthesis of natural metabolites concerning their lifestyle. This study’s results indicated that despite having a low number of P450s, the pathogenic mycobacterial species used most of the available P450s to synthesize natural metabolites. In contrast, non-pathogenic mycobacterial species had fewer P450s playing a role in the biosynthesis of natural metabolites. This suggests that the lifestyle of mycobacterial species changed the P450 profiles vis a vis P450s playing a role in these species’ adaptation to different niches as observed in other bacterial species. Characterizing P450 biosynthetic gene cluster metabolites will provide insights into their role in mycobacterial physiology.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ijms24010149/s1.

Author Contributions

Conceptualization, K.S.; methodology, N.M.Z., T.P., D.R.N. and K.S.; software, N.M.Z., T.P., D.R.N. and K.S.; validation, N.M.Z., T.P., D.R.N. and K.S.; formal analysis, N.M.Z., T.P., D.R.N. and K.S.; investigation, N.M.Z., T.P., D.R.N. and K.S.; resources, D.R.N. and K.S.; data curation, N.M.Z., T.P., D.R.N. and K.S.; writing—original draft preparation, N.M.Z., T.P., D.R.N. and K.S.; writing—review and editing, N.M.Z., T.P., D.R.N. and K.S.; visualization, N.M.Z., T.P., D.R.N. and K.S.; supervision, K.S.; project administration, K.S.; funding acquisition, K.S. All authors have read and agreed to the published version of the manuscript.

Funding

Khajamohiddin Syed expresses sincere gratitude to the University of Zululand (Grant number C686). Master student Ntokozo Minenhle Zondo and Doctoral Student Tiara Padayachee thank the National Research Foundation (NRF), South Africa, for postgraduate scholarships (Grant numbers MN210621613863 and MND210504599108).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare that they have no conflict of interest and that the funders had no role in the design of the study, in the collection, analysis, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results.

References

  1. Yamazaki, H. Fifty Years of Cytochrome P450 Research; Springer Japan: Tokyo, Japan, 2014; p. IX. [Google Scholar]
  2. McLean, K.J.; Leys, D.; Munro, A.W. Microbial cytochrome P450s. In Cytochrome P450: Structure, Mechanism, and Biochemistry, 4th ed.; Oritz de Montellano, P.R., Ed.; Springer International Publishing: Berlin/Heidelberg, Germany, 2015; Chapter 6; pp. 261–407. [Google Scholar]
  3. Nelson, D.R. Cytochrome P450 diversity in the tree of life. Biochim. Biophys. Acta Proteins Proteom. 2018, 1866, 141–154. [Google Scholar] [CrossRef] [PubMed]
  4. Garfinkel, D. Studies on pig liver microsomes. I. Enzymic and pigment composition of different microsomal fractions. Arch. Biochem. Biophys. 1958, 77, 493–509. [Google Scholar] [CrossRef] [PubMed]
  5. Klingenberg, M. Pigments of rat liver microsomes. Arch. Biochem. Biophys. 1958, 75, 376–386. [Google Scholar] [CrossRef] [PubMed]
  6. Omura, T. Recollection of the early years of the research on cytochrome P450. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2011, 87, 617–640. [Google Scholar] [CrossRef] [Green Version]
  7. Omura, T.; Sato, R. A new cytochrome in liver microsomes. J. Biol. Chem. 1962, 237, 1375–1376. [Google Scholar] [CrossRef]
  8. White, R.E.; Coon, M.J. Oxygen activation by cytochrome P-450. Annu. Rev. Biochem. 1980, 49, 315–356. [Google Scholar] [CrossRef]
  9. Bernhardt, R. Cytochromes P450 as versatile biocatalysts. J. Biotechnol. 2006, 124, 128–145. [Google Scholar] [CrossRef]
  10. Sono, M.; Roach, M.P.; Coulter, E.D.; Dawson, J.H. Heme-containing oxygenases. Chem. Rev. 1996, 96, 2841–2888. [Google Scholar] [CrossRef]
  11. Yan, Y.; Wu, J.; Hu, G.; Gao, C.; Guo, L.; Chen, X.; Liu, L.; Song, W. Current state and future perspectives of cytochrome P450 enzymes for C–H and C= C oxygenation. Synth. Syst. Biotechnol. 2022, 7, 887–899. [Google Scholar] [CrossRef]
  12. Li, Z.; Jiang, Y.; Guengerich, F.P.; Ma, L.; Li, S.; Zhang, W. Engineering cytochrome P450 enzyme systems for biomedical and biotechnological applications. J. Biol. Chem. 2020, 295, 833–849. [Google Scholar] [CrossRef]
  13. Urlacher, V.B.; Girhard, M. Cytochrome P450 Monooxygenases in Biotechnology and Synthetic Biology. Trends Biotechnol. 2019, 37, 882–897. [Google Scholar] [CrossRef] [PubMed]
  14. Girvan, H.M.; Munro, A.W. Applications of microbial cytochrome P450 enzymes in biotechnology and synthetic biology. Curr. Opin. Chem. Biol. 2016, 31, 136–145. [Google Scholar] [CrossRef] [PubMed]
  15. Kelly, S.L.; Kelly, D.E. Microbial cytochromes P450: Biodiversity and biotechnology. Where do cytochromes P450 come from, what do they do and what can they do for us? Philos. Trans. R. Soc. London Ser. B Biol. Sci. 2013, 368, 20120476. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Lepesheva, G.I.; Friggeri, L.; Waterman, M.R. CYP51 as drug targets for fungi and protozoan parasites: Past, present and future. Parasitology 2018, 145, 1820–1836. [Google Scholar] [CrossRef]
  17. Jawallapersand, P.; Mashele, S.S.; Kovacic, L.; Stojan, J.; Komel, R.; Pakala, S.B.; Krasevec, N.; Syed, K. Cytochrome P450 monooxygenase CYP53 family in fungi: Comparative structural and evolutionary analysis and its role as a common alternative anti-fungal drug target. PLoS ONE 2014, 9, e107209. [Google Scholar] [CrossRef] [Green Version]
  18. Lamb, D.C.; Follmer, A.H.; Goldstone, J.V.; Nelson, D.R.; Warrilow, A.G.; Price, C.L.; True, M.Y.; Kelly, S.L.; Poulos, T.L.; Stegeman, J.J. On the occurrence of cytochrome P450 in viruses. Proc. Natl. Acad. Sci. USA 2019, 116, 12343–12352. [Google Scholar] [CrossRef] [Green Version]
  19. Nelson, D.R. Cytochrome P450 nomenclature. Methods Mol. Biol. 1998, 107, 15–24. [Google Scholar]
  20. Nelson, D.R. Cytochrome P450 nomenclature, 2004. Methods Mol. Biol. 2006, 320, 1–10. [Google Scholar]
  21. Nelson, D.R. The cytochrome p450 homepage. Hum. Genom. 2009, 4, 59–65. [Google Scholar] [CrossRef] [Green Version]
  22. Nelson, D.R.; Kamataki, T.; Waxman, D.J.; Guengerich, F.P.; Estabrook, R.W.; Feyereisen, R.; Gonzalez, F.J.; Coon, M.J.; Gunsalus, I.C.; Gotoh, O.; et al. The P450 superfamily: Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol. 1993, 12, 1–51. [Google Scholar] [CrossRef]
  23. Rudolf, J.D.; Chang, C.Y.; Ma, M.; Shen, B. Cytochromes P450 for natural product biosynthesis in Streptomyces: Sequence, structure, and function. Nat. Prod. Rep. 2017, 34, 1141–1172. [Google Scholar] [CrossRef] [PubMed]
  24. Podust, L.M.; Sherman, D.H. Diversity of P450 enzymes in the biosynthesis of natural products. Nat. Prod. Rep. 2012, 29, 1251–1266. [Google Scholar] [CrossRef] [PubMed]
  25. Greule, A.; Stok, J.E.; De Voss, J.J.; Cryle, M.J. Unrivalled diversity: The many roles and reactions of bacterial cytochromes P450 in secondary metabolism. Nat. Prod. Rep. 2018, 35, 757–791. [Google Scholar] [CrossRef] [Green Version]
  26. Medema, M.H.; Kottmann, R.; Yilmaz, P.; Cummings, M.; Biggins, J.B.; Blin, K.; de Bruijn, I.; Chooi, Y.H.; Claesen, J.; Coates, R.C.; et al. Minimum Information about a Biosynthetic Gene cluster. Nat. Chem. Biol. 2015, 11, 625–631. [Google Scholar] [CrossRef] [PubMed]
  27. Khumalo, M.J.; Nzuza, N.; Padayachee, T.; Chen, W.; Yu, J.H.; Nelson, D.R.; Syed, K. Comprehensive Analyses of Cytochrome P450 Monooxygenases and Secondary Metabolite Biosynthetic Gene Clusters in Cyanobacteria. Int. J. Mol. Sci. 2020, 21, 656. [Google Scholar] [CrossRef] [Green Version]
  28. Malinga, N.A.; Nzuza, N.; Padayachee, T.; Syed, P.R.; Karpoormath, R.; Gront, D.; Nelson, D.R.; Syed, K. An Unprecedented Number of Cytochrome P450s Are Involved in Secondary Metabolism in Salinispora Species. Microorganisms 2022, 10, 871. [Google Scholar] [CrossRef]
  29. Msomi, N.N.; Padayachee, T.; Nzuza, N.; Syed, P.R.; Kryś, J.D.; Chen, W.; Gront, D.; Nelson, D.R.; Syed, K. In silico analysis of P450s and their role in secondary metabolism in the bacterial class Gammaproteobacteria. Molecules 2021, 26, 1538. [Google Scholar] [CrossRef]
  30. Msweli, S.; Chonco, A.; Msweli, L.; Syed, P.R.; Karpoormath, R.; Chen, W.; Gront, D.; Nkosi, B.V.Z.; Nelson, D.R.; Syed, K. Lifestyles Shape the Cytochrome P450 Repertoire of the Bacterial Phylum Proteobacteria. Int. J. Mol. Sci. 2022, 23, 5821. [Google Scholar] [CrossRef]
  31. Mthethwa, B.C.; Chen, W.; Ngwenya, M.L.; Kappo, A.P.; Syed, P.R.; Karpoormath, R.; Yu, J.H.; Nelson, D.R.; Syed, K. Comparative analyses of cytochrome P450s and those associated with secondary metabolism in Bacillus species. Int. J. Mol. Sci. 2018, 19, 3623. [Google Scholar] [CrossRef] [Green Version]
  32. Nkosi, B.V.Z.; Padayachee, T.; Gront, D.; Nelson, D.R.; Syed, K. Contrasting Health Effects of Bacteroidetes and Firmicutes Lies in Their Genomes: Analysis of P450s, Ferredoxins, and Secondary Metabolite Clusters. Int. J. Mol. Sci. 2022, 23, 5057. [Google Scholar] [CrossRef]
  33. Nzuza, N.; Padayachee, T.; Syed, P.R.; Kryś, J.D.; Chen, W.; Gront, D.; Nelson, D.R.; Syed, K. Ancient Bacterial Class Alphaproteobacteria Cytochrome P450 Monooxygenases Can Be Found in Other Bacterial Species. Int. J. Mol. Sci. 2021, 22, 5542. [Google Scholar] [CrossRef] [PubMed]
  34. Padayachee, T.; Nzuza, N.; Chen, W.; Nelson, D.R.; Syed, K. Impact of lifestyle on cytochrome P450 monooxygenase repertoire is clearly evident in the bacterial phylum Firmicutes. Sci. Rep. 2020, 10, 1–12. [Google Scholar] [CrossRef] [PubMed]
  35. Parvez, M.; Qhanya, L.B.; Mthakathi, N.T.; Kgosiemang, I.K.; Bamal, H.D.; Pagadala, N.S.; Xie, T.; Yang, H.; Chen, H.; Theron, C.W.; et al. Molecular evolutionary dynamics of cytochrome P450 monooxygenases across kingdoms: Special focus on mycobacterial P450s. Sci. Rep. 2016, 6, 33099. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Senate, L.M.; Tjatji, M.P.; Pillay, K.; Chen, W.; Zondo, N.M.; Syed, P.R.; Mnguni, F.C.; Chiliza, Z.E.; Bamal, H.D.; Karpoormath, R.; et al. Similarities, variations, and evolution of cytochrome P450s in Streptomyces versus Mycobacterium. Sci. Rep. 2019, 9, 3962. [Google Scholar] [CrossRef] [Green Version]
  37. Mnguni, F.C.; Padayachee, T.; Chen, W.; Gront, D.; Yu, J.-H.; Nelson, D.R.; Syed, K. More P450s are involved in secondary metabolite biosynthesis in Streptomyces compared to Bacillus, Cyanobacteria and Mycobacterium. Int. J. Mol. Sci. 2020, 21, 4814. [Google Scholar] [CrossRef] [PubMed]
  38. Ortiz de Montellano, P.R. Potential drug targets in the Mycobacterium tuberculosis cytochrome P450 system. J. Inorg. Biochem. 2018, 180, 235–245. [Google Scholar] [CrossRef]
  39. Van Beilen, J.B.; Holtackers, R.; Lüscher, D.; Bauer, U.; Witholt, B.; Duetz, W.A. Biocatalytic production of perillyl alcohol from limonene by using a novel Mycobacterium sp. cytochrome P450 alkane hydroxylase expressed in Pseudomonas putida. Appl. Environ. Microbiol. 2005, 71, 1737–1744. [Google Scholar] [CrossRef] [Green Version]
  40. Sogi, K.M.; Holsclaw, C.M.; Fragiadakis, G.K.; Nomura, D.K.; Leary, J.A.; Bertozzi, C.R. Biosynthesis and Regulation of Sulfomenaquinone, a Metabolite Associated with Virulence in Mycobacterium tuberculosis. ACS Infect. Dis. 2016, 2, 800–806. [Google Scholar] [CrossRef] [Green Version]
  41. Syed, P.R.; Chen, W.; Nelson, D.R.; Kappo, A.P.; Yu, J.H.; Karpoormath, R.; Syed, K. Cytochrome P450 Monooxygenase CYP139 Family Involved in the Synthesis of Secondary Metabolites in 824 Mycobacterial Species. Int. J. Mol. Sci. 2019, 20, 2690. [Google Scholar] [CrossRef] [Green Version]
  42. Quadri, L.E. Biosynthesis of mycobacterial lipids by polyketide synthases and beyond. Crit. Rev. Biochem. Mol. Biol. 2014, 49, 179–211. [Google Scholar] [CrossRef]
  43. Ghazaei, C. Mycobacterium tuberculosis and lipids: Insights into molecular mechanisms from persistence to virulence. J. Res. Med. Sci. 2018, 23, 63. [Google Scholar] [CrossRef] [PubMed]
  44. Bansal-Mutalik, R.; Nikaido, H. Mycobacterial outer membrane is a lipid bilayer and the inner membrane is unusually rich in diacyl phosphatidylinositol dimannosides. Proc. Natl. Acad. Sci. USA 2014, 111, 4958–4963. [Google Scholar] [CrossRef] [PubMed]
  45. Van Wyk, R.; van Wyk, M.; Mashele, S.S.; Nelson, D.R.; Syed, K. Comprehensive comparative analysis of cholesterol catabolic genes/proteins in mycobacterial species. Int. J. Mol. Sci. 2019, 20, 1032. [Google Scholar] [CrossRef] [Green Version]
  46. Ngcobo, N.S.; Chiliza, Z.E.; Chen, W.; Yu, J.-H.; Nelson, D.R.; Tuszynski, J.A.; Preto, J.; Syed, K. Comparative Analysis, Structural Insights, and Substrate/Drug Interaction of CYP128A1 in Mycobacterium tuberculosis. Int. J. Mol. Sci. 2020, 21, 4816. [Google Scholar] [CrossRef] [PubMed]
  47. Belin, P.; Le Du, M.H.; Fielding, A.; Lequin, O.; Jacquet, M.; Charbonnier, J.B.; Lecoq, A.; Thai, R.; Courcon, M.; Masson, C.; et al. Identification and structural basis of the reaction catalyzed by CYP121, an essential cytochrome P450 in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 2009, 106, 7426–7431. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  48. Nguyen, R.C.; Yang, Y.; Wang, Y.; Davis, I.; Liu, A. Substrate-assisted hydroxylation and O-demethylation in the peroxidase-like cytochrome P450 enzyme CYP121. ACS Catal. 2019, 10, 1628–1639. [Google Scholar] [CrossRef]
  49. Rajput, S.; McLean, K.J.; Poddar, H.; Selvam, I.R.; Nagalingam, G.; Triccas, J.A.; Levy, C.W.; Munro, A.W.; Hutton, C.A. Structure–activity relationships of cyclo (L-tyrosyl-L-tyrosine) derivatives binding to Mycobacterium tuberculosis CYP121: Iodinated analogues promote shift to high-spin adduct. J. Med. Chem. 2019, 62, 9792–9805. [Google Scholar] [CrossRef]
  50. Johnston, J.B.; Kells, P.M.; Podust, L.M.; Ortiz de Montellano, P.R. Biochemical and structural characterization of CYP124: A methyl-branched lipid omega-hydroxylase from Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 2009, 106, 20687–20692. [Google Scholar] [CrossRef] [Green Version]
  51. Johnston, J.B.; Ouellet, H.; Ortiz de Montellano, P.R. Functional redundancy of steroid C26-monooxygenase activity in Mycobacterium tuberculosis revealed by biochemical and genetic analyses. J. Biol. Chem. 2010, 285, 36352–36360. [Google Scholar] [CrossRef] [Green Version]
  52. Chen, I.-M.A.; Chu, K.; Palaniappan, K.; Ratner, A.; Huang, J.; Huntemann, M.; Hajek, P.; Ritter, S.; Varghese, N.; Seshadri, R. The IMG/M data management and analysis system v. 6.0: New tools and advanced capabilities. Nucleic Acids Res. 2021, 49, D751–D763. [Google Scholar] [CrossRef]
  53. Ventura, M.; Canchaya, C.; Tauch, A.; Chandra, G.; Fitzgerald, G.F.; Chater, K.F.; van Sinderen, D. Genomics of Actinobacteria: Tracing the evolutionary history of an ancient phylum. Microbiol. Mol. Biol. Rev. 2007, 71, 495–548. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Tortoli, E. Phylogeny of the genus Mycobacterium: Many doubts, few certainties. Infect. Genet. Evol. 2012, 12, 827–831. [Google Scholar] [CrossRef] [PubMed]
  55. Syed, K.; Mashele, S.S. Comparative analysis of P450 signature motifs EXXR and CXG in the large and diverse kingdom of fungi: Identification of evolutionarily conserved amino acid patterns characteristic of P450 family. PLoS ONE 2014, 9, e95616. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  56. Gotoh, O. Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. J. Biol. Chem. 1992, 267, 83–90. [Google Scholar] [CrossRef] [PubMed]
  57. Blin, K.; Pascal Andreu, V.; de Los Santos, E.L.C.; Del Carratore, F.; Lee, S.Y.; Medema, M.H.; Weber, T. The antiSMASH database version 2: A comprehensive resource on secondary metabolite biosynthetic gene clusters. Nucleic Acids Res. 2019, 47, D625–D630. [Google Scholar] [CrossRef] [PubMed]
Ijms 24 00149 g001 550
Figure 1. Comparative analysis of P450 families in 2666 mycobacterial species. P450 families with >1000 members were presented in the figure. The P450 family name and number of P450s are shown in the figure. Detailed information on P450 families and subfamilies is presented in Table S3.
Figure 1. Comparative analysis of P450 families in 2666 mycobacterial species. P450 families with >1000 members were presented in the figure. The P450 family name and number of P450s are shown in the figure. Detailed information on P450 families and subfamilies is presented in Table S3.
Ijms 24 00149 g001
Ijms 24 00149 g002 550
Figure 2. Comparative analysis of P450s families in six mycobacterial categories. The P450 family, members, and their percentage in the total number of P450s in a category are presented in the figure. Abbreviations: MTBC, Mycobacterium tuberculosis complex; MCAC, M. chelonae-abscessus complex; MAC, M. avium complex; MCL, Mycobacteria causing leprosy; NTM, Nontuberculous mycobacteria and SAP, Saprophytes. Detailed information on P450 families with their specific count for each mycobacterial category is presented in Table S4.
Figure 2. Comparative analysis of P450s families in six mycobacterial categories. The P450 family, members, and their percentage in the total number of P450s in a category are presented in the figure. Abbreviations: MTBC, Mycobacterium tuberculosis complex; MCAC, M. chelonae-abscessus complex; MAC, M. avium complex; MCL, Mycobacteria causing leprosy; NTM, Nontuberculous mycobacteria and SAP, Saprophytes. Detailed information on P450 families with their specific count for each mycobacterial category is presented in Table S4.
Ijms 24 00149 g002
Ijms 24 00149 g003 550
Figure 3. Comparative analysis of P450s involved in natural metabolite biosynthesis in mycobacterial species. The number next to the bars represents the number of members in a P450 family. Detailed information on the P450s part of biosynthetic gene clusters (BGCs), their species names, and BGC types are presented in Table S6. An analysis of the member P450s part BGCs as per their mycobacterial categories is presented in Table S7.
Figure 3. Comparative analysis of P450s involved in natural metabolite biosynthesis in mycobacterial species. The number next to the bars represents the number of members in a P450 family. Detailed information on the P450s part of biosynthetic gene clusters (BGCs), their species names, and BGC types are presented in Table S6. An analysis of the member P450s part BGCs as per their mycobacterial categories is presented in Table S7.
Ijms 24 00149 g003
Ijms 24 00149 g004 550
Figure 4. Comparative analysis of P450s that are part of biosynthetic gene clusters (BGCs) in mycobacterial categories. Detailed information on the P450s part of BGCs, their species names, and BGC types are presented in Table S6. A P450 family analysis in individual categories is presented in Table S7. Abbreviations: MTBC, Mycobacterium tuberculosis complex; MCAC, M. chelonae-abscessus complex; MAC, M. avium complex; MCL, Mycobacteria causing leprosy; NTM, Nontuberculous mycobacteria; and SAP, Saprophytes.
Figure 4. Comparative analysis of P450s that are part of biosynthetic gene clusters (BGCs) in mycobacterial categories. Detailed information on the P450s part of BGCs, their species names, and BGC types are presented in Table S6. A P450 family analysis in individual categories is presented in Table S7. Abbreviations: MTBC, Mycobacterium tuberculosis complex; MCAC, M. chelonae-abscessus complex; MAC, M. avium complex; MCL, Mycobacteria causing leprosy; NTM, Nontuberculous mycobacteria; and SAP, Saprophytes.
Ijms 24 00149 g004
Table
Table 1. Comparative analysis of key features of P450s and their association with secondary metabolism in different bacterial species. Abbreviation: No., number of; BGCs: biosynthetic gene clusters.
Table 1. Comparative analysis of key features of P450s and their association with secondary metabolism in different bacterial species. Abbreviation: No., number of; BGCs: biosynthetic gene clusters.
CategorySalinispora speciesStreptomyces speciesMycobacterial speciesCyanobacterial speciesBacteroidetes speciesFirmicutes speciesAlphaproteobacterial speciesBetaproteobacterial speciesGammaproteobacterial speciesDeltaproteobacterial speciesEpsilonproteobacterial species
Species analyzed12620326661143349725995131261107216
Species with P450s1262032666114772292292901692353
Percentage of species with P450s10010010010023243857132125
No. of P450s2643546062,8153419871287360327733353
No. of families452531823621141437981742
No. of subfamilies1036983457928532141191021712
Dominant P450 familyCYP105CYP107CYP135CYP110CYP1103CYP107CYP202CYP116CYP133 & CYP107CYP107CYP172
Average No. of P450s212724313422141
No. of P450s part of BGCs1236123193992781262110749690
No. of P450 families part of BGCs35135686510161822370
Percentage of P450s part of BGCs472315881821818210
Reference(s)[28][36,37]This work[27][32][34][33][30][29][30][30]
Table
Table 2. Comparative analysis of key features of P450s and their association with secondary metabolism in mycobacterial categories. A statistical analysis of P450 counts among different mycobacterial categories was presented in Table S2. Abbreviations: MTBC, Mycobacterium tuberculosis complex; MCAC, M. chelonae-abscessus complex; MAC, M. avium complex; MCL, Mycobacteria causing leprosy; NTM, nontuberculous mycobacteria; and SAP, Saprophytes; No., number of; BGCs, biosynthetic gene clusters.
Table 2. Comparative analysis of key features of P450s and their association with secondary metabolism in mycobacterial categories. A statistical analysis of P450 counts among different mycobacterial categories was presented in Table S2. Abbreviations: MTBC, Mycobacterium tuberculosis complex; MCAC, M. chelonae-abscessus complex; MAC, M. avium complex; MCL, Mycobacteria causing leprosy; NTM, nontuberculous mycobacteria; and SAP, Saprophytes; No., number of; BGCs, biosynthetic gene clusters.
CategoryMTBCMCACNTMMACSAPMCL
Total No. of species analysed2128255163106104
Total No. of P450s42,91765197760509350521
P450 fragments/pseudo21069360
Average No. of P450s20264848515
Min No. of P450s522928353
Maximum No. of P450s74528969957
No. of P450 families663714559669
No of P450 subfamilies9548261881019
Dominant P450 familyCYP135CYP125CYP125CYP150CYP189CYP136 & CYP184
No of the P450s part of BGCs8153438450328300
No. of P450 families part of BGCs19135611150
Percentage of P450s part of BGCs19.06.75.86.45.90
Percentage of P450 families part of BGCs28.835.138.618.622.70
Table
Table 3. Analysis of P450 subfamily blooming/expansion in mycobacterial species. Subfamily information for P450 families with >500 members is presented in the table, along with the nature of the subfamily (blooming/expansion). A detailed analysis of P450 subfamilies is shown in Table S3.
Table 3. Analysis of P450 subfamily blooming/expansion in mycobacterial species. Subfamily information for P450 families with >500 members is presented in the table, along with the nature of the subfamily (blooming/expansion). A detailed analysis of P450 subfamilies is shown in Table S3.
P450 FamilyCountSubfamilyCountNature of the Subfamily
CYP1233019A2908Bloomed
CYP1254085A3978Bloomed
CYP1363017A2687Bloomed
CYP105674Q377Expanded
CYP108714B703Expanded
CYP1212029A2029Expanded
CYP1242484A2425Expanded
CYP1262434A2429Expanded
CYP1282243A2143Expanded
CYP1302640A2640Expanded
CYP1322160A2160Expanded
CYP1354702A2149Expanded
B2543Expanded
CYP1372167A2167Expanded
CYP1382810A2733Expanded
CYP1392286A2286Expanded
CYP1402810A2401Expanded
CYP1412105A2105Expanded
CYP1422540A2507Expanded
CYP1432470A2387Expanded
CYP1442700A2421Expanded
CYP1501056A932Expanded
CYP164514A505Expanded
CYP1891002A987Expanded
CYP512680B2680Expanded
Table
Table 4. Analysis of unique and shared P450 families among mycobacterial categories. The P450 family dominantly shared between mycobacterial categories is listed in parenthesis. A detailed analysis of P450 families and their member count is presented in Table S5. Abbreviations: MTBC, Mycobacterium tuberculosis complex; MCAC, M. chelonae-abscessus complex; MAC, M. avium complex; MCL, Mycobacteria causing leprosy; NTM, Nontuberculous mycobacteria; and SAP, Saprophytes.
Table 4. Analysis of unique and shared P450 families among mycobacterial categories. The P450 family dominantly shared between mycobacterial categories is listed in parenthesis. A detailed analysis of P450 families and their member count is presented in Table S5. Abbreviations: MTBC, Mycobacterium tuberculosis complex; MCAC, M. chelonae-abscessus complex; MAC, M. avium complex; MCL, Mycobacteria causing leprosy; NTM, Nontuberculous mycobacteria; and SAP, Saprophytes.
CategoryMTBCMCACNTMMACSAPMCL
MTBC1122 (CYP125)49 (CYP189)36 (CYP150)34 (CYP189)8 (CYP136 & CYP164)
MCAC22 (CYP125)628 (CYP125)20 (CYP105)19 (CYP125)5 (CYP136 & CYP164)
NTM49 (CYP189)28 (CYP125)7134 (CYP189)29 (CYP189)7 (CYP164)
MAC36 (CYP150)20 (CYP105)34 (CYP189)1525 (CYP189)9 (CYP136 & CYP164)
SAP34 (CYP189)19 (CYP125)29 (CYP189)27 (CYP189)235 (CYP136)
MCL8 (CYP136 & CYP164)5 (CYP136 & CYP164)7 (CYP164)9 (CYP136 & CYP164)5 (CYP136)0
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Zondo, N.M.; Padayachee, T.; Nelson, D.R.; Syed, K. Saprophytic to Pathogenic Mycobacteria: Loss of Cytochrome P450s Vis a Vis Their Prominent Involvement in Natural Metabolite Biosynthesis. Int. J. Mol. Sci. 2023, 24, 149. https://doi.org/10.3390/ijms24010149

AMA Style

Zondo NM, Padayachee T, Nelson DR, Syed K. Saprophytic to Pathogenic Mycobacteria: Loss of Cytochrome P450s Vis a Vis Their Prominent Involvement in Natural Metabolite Biosynthesis. International Journal of Molecular Sciences. 2023; 24(1):149. https://doi.org/10.3390/ijms24010149

Chicago/Turabian Style

Zondo, Ntokozo Minenhle, Tiara Padayachee, David R. Nelson, and Khajamohiddin Syed. 2023. "Saprophytic to Pathogenic Mycobacteria: Loss of Cytochrome P450s Vis a Vis Their Prominent Involvement in Natural Metabolite Biosynthesis" International Journal of Molecular Sciences 24, no. 1: 149. https://doi.org/10.3390/ijms24010149

APA Style

Zondo, N. M., Padayachee, T., Nelson, D. R., & Syed, K. (2023). Saprophytic to Pathogenic Mycobacteria: Loss of Cytochrome P450s Vis a Vis Their Prominent Involvement in Natural Metabolite Biosynthesis. International Journal of Molecular Sciences, 24(1), 149. https://doi.org/10.3390/ijms24010149

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop